Thank you! Your request has been received.
A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+
Knolens DataNexus is an enterprise-grade pharmaceutical data aggregation platform that unifies, validates, and harmonizes data across the global life sciences ecosystem. Designed for pharma, biotech, and CROs in hubs like Boston, New Jersey, Basel, and London, it solves the challenge of fragmented clinical, regulatory, and competitive intelligence.
The platform automatically integrates real-time data streams from:
DataNexus ensures 98%+ accuracy with validated clinical, scientific, and regulatory data—backed by audit trails for FDA and EMA compliance.
With sub-24 hour freshness, DataNexus delivers up-to-date intelligence for drug development, regulatory strategy, and competitive positioning
DataNexus unifies structured (trials, filings) and unstructured data (PDFs, publications, press releases) into one AI-powered system. Pharma teams can analyze all sources in a single platform—eliminating silos and weeks of manual work.
Access comprehensive life sciences intelligence from clinical trial registries, medical literature databases, regulatory agencies, patent offices, and market intelligence sources across North America, Europe, and Asia-Pacific pharmaceutical markets.
Natural language queries deliver answers in <5 seconds for complex questions like
"Which KRAS G12C inhibitors are in Phase 2+ trials with overall response rates >30%?" or
"Compare FDA vs EMA approval timelines for CAR-T therapies in hematologic malignancies."
DataNexus integrates real-time insights into pharma systems via secure APIs (Veeva Vault, SharePoint, proprietary platforms):
Together, it unifies intelligence, strengthens institutional memory, and accelerates drug development decisions.
From oncology to neuroscience, rare diseases to precision medicine, DataNexus powers therapeutic insights, real-world outcomes, and predictive biomarkers—delivering 98%+ accuracy with full regulatory compliance.
